Volume : 10, Issue : 08, August – 2023
Title:
02.REVIEW OF LIPOSPHERE CONTAINING CHLORTHALIDON SUSPENSION FOR ORAL DELIVERY
Authors :
Mr. Vaibhav Kishor Patil, Dr. Sandip Ramesh Pawar
Abstract :
The present investigation of this work “To Design and Development of Liposphere Containing Chlorthalidon Suspension for Oral Delivery” were developed and leads to liposphere, present work explain the mechanism of Liposphere release from Suspension In this work particles were prepared by using Cetyl alcohol consisting of Cetostearyl alcohol Xanthum gum, which can be act as a suspending agents. Melt dispersion method based on Though number of micro encapsulation technique have been employed to produce polymeric multiparticulate system, The morphological characterization of the optimized liposphere were examined by scanning electron microscope with suitable magnification
Keywords: Liposphere, Chlorthalidon, Phospholipids
Cite This Article:
Please cite this article in press Vaibhav Kishor Patil et al, Review Of Liposphere Containing Chlorthalidon Suspension For Oral Delivery, Indo Am. J. P. Sci, 2023; 10 (08).
Number of Downloads : 10
References:
1. Rossi M. Use of lecithin and lecithin fractions [M]. Bioactive Egg Compounds. Springer. 2007; 229 – 239.
2. Hager AA, de Paoli T, Ihlo JE, Farach HA, Poole CP. Stability study of lecithin liposomes during storage using ESR. SpectrochimActa. 1993; 49(13): 1999 – 2005.
3. Paltauf F, Hermetter A. Phospholipids – Biochemical Pharmaceutical and analytical consideration. Phospholipids natural, semisynthetic, synthetic. Phospholipids. Springer Science Business media. NewYork. 1990; 1-12.
4. Terao J, Hirota M, Kawakatsu M, Matsushita S. Structural analysis of hydroperoxides formed by oxidation of phosphotidylcholine with singlet oxygen. Lipids 1981; 16(6): 427-432.
5. Rawat M, Singh S, Saraf S. Nano carriers: Promising vehicle for bioactive drugs, Biol and Pharm Bull. 2006; 29(9): 1790 -1798.
6. Nasr M, Mansour S, Mortada ND, El Shamy A. Lipospheres as Carriers for Topical Delivery of Aceclofenac Preparation, Characterization and In Vivo Evaluation. AAPS PharmSciTech, 2008; 9(1):154-162.
7. Gohel M, Amin A. Development and Evaluation of lipospheres of Diclofenac sodium. Indian J Pharm Sci, 1997; 59(2): 85.
8. Barakat NS, Yassin AEB. In vitro characterization of carbamazepine-loaded precifac lipospheres Drug Delivery. 2006; 13(2): 95-104.
9. Reithermeier H, Herrmann J, Göpferich. Lipid micro particles as a parenteral controlled release device for peptides. J Control Release. 2001; 73(2-3):339- 350.
10. Westensen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchrotron radiation x-ray diffraction. Int J Pharm. 1993; 93: 189-199.
11. Attama AA, Nkemnele MO. In vitro evaluation of drug release from self micro-emulsifying drug Delivery Systems using a biodegradable homolipid from Capra hircus. Int J pharm 2005; 304: 4-10.
12. Domb, Abraham J, Maniar, Manoj. Lipospheres for controlled delivery of substances. European patent EP0502119. 1996.
13. Rawat M, Saraf S. Lipospheres; emerging carriers for proteins and peptides. Int J Pharm Sci Nanotech. 2008; 1: 207-213.
14. Lee JH, Park TG , Choi HK. Effect of formulation and processing variables on the characteristics of microspheres for water soluble drugs prepared by w/o/o double emulsion solvent diffusion method. Int JPharm 2002;196: 75- 83.
15. Domb AJ, Maniar M. Liposphere for control delivery of substances. PCT Patent Application.WO91/07171 1991.
16. Domb AJ. Liposphere parenteral delivery system. Proceed Intern Symp Control Rel Bioact Mater . 1993; 20: 121.
17. Mithilesh Payasi, Mithum Bhowmick, Girijesh Kumar Pandey, Amit Joshi, Balakrishna Dubey. Development and Characterization of Pioglitazone loaded Liposphere for the Effective Treatment of Diabetes Mellitus Type 2. Int J Biomed Adv Res. 2013; 4(10): 737-748.
18. Khulbe Preeti, Munjal Priyanka. Formulation and Evaluation of Vinpocetine loaded Lipospheres. Int J Pharm Pharm Sci. 2012; 4(3): 470-473.
19. Cortesi R, Esposito E, Luca G, Nastruzzi C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002; 23: 2283-94.
20. Claudio Nastruzzi, Lipospheres in drug targets and delivery, approaches, methods and applications. New York: Washington, 2005.
21. SatheeshBabu Natarajan, Prabakaran L, Gayathri Rajaram, Arun Ganesh Kumar, Sundareswara Kumar C, Arthi I. Design and Development of Lipospheres for Controlled Delivery for Anti -malarial drugs. Int J Pharm Pharm Sci. 2012; 4 (4): 87-92.
22. Leeladhar Prajapati PS, Kawtikwar DM, Sakarkar, Swanand Malode. Recent Advances in Various Drug Delivery Systems. Int J PharmTechno 2013; 5 (1): 2446-2464.
23. Tursilli R, Casolari A, Lannuccelli V, Scalia S. Enhancement of Melatonin photostability by encapsulation in lipospheres. J Pharm Biomed Anal. 2006; 40: 910-914.
24. Hagalavadi Nanjappa Shivakumar, Pragnesh Bharat Patel, Bapusaheb Gangadhar Desai, Purnima Ashok, Sinnathambi Arulmozhi. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta Pharm. 2007; 57: 269–285.
25. Gohel M, Amin A. Development and Evaluation of lipospheres of Diclofenac sodium. Indian J Pharm Sci, 1997; 59(2): 85.
26. Barakat NS, Yassin AEB. In vitro characterization of carbamazepine-loaded precifac lipospheres. 2006; Drug Delivery,13(2): 95-104.
27. Reithermeier H, Herrmann J, Göpferich. Development and characterization of lipid microparticle as a drug carrier for somatostatin. Int J Pharm 2001; 218: 133-143.
28. Morais HA, Da Silva Barbosa CM, Delvivo FM, Mansur HS, Critina Deo. Comparative study of microencapsulation of casein hydrolysates in lipospheres and liposomes. J Food Biochem.2004; 28(1): 21-41.
29. Amselem S, Alving CR, Domb AJ. Polymeric biodegradable liposphere TM as vaccine delivery systems. Polym Adv Technol., 1992; 3(6): 351-357.
30. Tosi A, Mazzitelli S, Bozzuuto N, Britini B, Luca G Naztruzzi C. Tripalmitin – Based Cationic lipospheres: preparation, characterization and in Lab-on-a- chip applications. J Control Releas., 2006; 116(2): e5